Tab Article
- Global and genetic outlook: Future trends in diabetes burden, global epidemiology and risk factors, genetics and epigenetics evolution, type 1 diabetes immunotherapy, emerging early detection biomarkers.
- Therapeutic innovations: Beta-cell regeneration advancements, new drug classes: SGLT2-I, GLP-1, dual agonists, precision medicine in diabetes care, pharmacotherapy tailoring and trials, surgery and weight-loss for remission.
- Technology-driven care: AI in prediction and treatment planning, wearables and continuous glucose monitoring, closed-loop insulin delivery systems, telemedicine for remote management, big data powering diabetes research.
- Holistic management approach: Addressing mental health and support, cardiovascular and kidney complication care, retinopathy and neuropathy prevention, lifestyle modification via diet and exercise, diabetes in special populations addressed.
- Policy, equity, and research frontiers: Public health and prevention strategies, global policies for improved care access, tackling disparities in diabetes outcomes, landmark RCTs and their implications, exploring cancer, microbiome, and sports links.
- Future-focused global and genetic insights
- Innovative therapies and drug advancements
- AI-powered, tech-integrated diabetes care
- Holistic, complication-aware management
- Policy, prevention, and equity-driven strategies
.jpg)
Sanjiv Kapoor
Verified PurchaseThe categories provided in medical books are so good. Also, the medical instruments at the given cost are a great deal